Maxillofacial Plastic and Reconstructive Surgery

Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지

GENE EXPRESSION FOR LYMPHANGIOGENIC FACTORS IN ORAL MUCOSAL SQUAMOUS CELL CARCINOMA

구강점막 편평상피세포암에서 림프관형성 유전자 발현

  • Park, Young-Wook (Department of Oral & Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Kim, Seong-Gon (Department of Oral & Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Kim, So-Hee (Department of Pharmacology, College of Dentistry, Gangneung-Wonju National University) ;
  • Kim, Han-Seok (Department of Oral & Maxillofacial Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine) ;
  • Kim, Min-Keun (Department of Dentistry, The Armed Forces Gangneung Hospital)
  • 박영욱 (강릉원주대학교 치과대학 구강악안면외과학교실) ;
  • 김성곤 (강릉원주대학교 치과대학 구강악안면외과학교실) ;
  • 김소희 (강릉원주대학교 치과대학 약리학교실) ;
  • 김한석 (울산의과대학교 강릉아산병원) ;
  • 김민근 (국군 강릉병원 치과)
  • Received : 2009.10.12
  • Accepted : 2009.11.10
  • Published : 2009.11.20
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Purpose: Vascular endothelial growth factor (VEGF)-C, VEGF-D and their tyrosine kinase receptor, VEGF receptor (VEGFR)-3 are recently known to have lymphangiogenic activities in various tumor types. Oral mucosal squamous cell carcinoma (OMSCC) easily metastasizes to cervical lymph nodes, so we determined the expression levels of VEGF-C, VEGF-D and VEGFR-3 in oral squamous cell carcinoma. Materials and Methods: We performed Western blot analyses with 4 OMSCC cultured tumor cell lines (SCC9, KB, YD-10B, YD-38), and with 7 surgical specimens of OMSCC for the detection of VEGF-C, VEGF-D and VEGFR-3 proteins. Expression of VEGF-C mRNA as well as mRNA for VEGFR-3 in 4 OMSCC cell lines (KB, SCC-4, SCC-9, YD-10B) was investigated by RT-PCR. We also measured VEGFC/VEGF-D protein concentrations in the media and protein concentration of VEGFR-3 in cell lysates of 4 OMSCC cell lines (SCC9, KB, YD-10B, YD-38) using commerical ELISA kits. Finally, we performed immunoprecipitation for the detection of VEGF-C in cell lysates of 4 OMSCC cells (KB, SCC-4, SCC-9, YD-10B) and real-time RT-PCR for the quantification of VEGF-C mRNA. Results: In the result of Western blotting with cell lysates of 4 OMSCC cells, we could not detect the protein expression of VEGF-C, VEGF-D, and VEGFR-3. But, all tumor tissues demonstrated VEGF-C and VEGFR-3. VEGF-C mRNA was detected at various levels in 4 OMSCC cell lines. Moreover, OMSCC cells secreted VEGF-C, not VEGF-D and VEGFR-3 was also detected in cell lysates of OMSCC by ELISA. Immunoprecipitation and real-time RT-PCR revealed VEGF-C was also expressed in 4 OMSCC cell lines. Conclusion: Taken together, tumor cells of OMSCC secrete VEGF-C, not VEGF-D. And VEGFR-3 is expressed tumor cells as well as OMSCC tumor tissues, needs further study.

Keywords

References

  1. Oliver G, Harvey N : A stepwise model of the development of lymphatic vasculature. Ann NY Acad Sci 979 : 159, 2002 https://doi.org/10.1111/j.1749-6632.2002.tb04876.x
  2. Cochran AJ, Wen DR, Morton DL : Management of the ragional lymph nodes in patients with cutaneous malignant melanoma. World J Surg 16 : 214, 1992 https://doi.org/10.1007/BF02071523
  3. Bilde A, von Buchwald C, Therkildsen MH et al : Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope 118(3) : 408, 2008 https://doi.org/10.1097/MLG.0b013e31815d8e15
  4. Grandi C, Alloisio M, Moglia D et al : Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications. Head Neck Surg 8 : 67, 1985 https://doi.org/10.1002/hed.2890080202
  5. Silverman S Jr : Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Amer Dent Assoc 132(Suppl) : 7S-11S, 2001 https://doi.org/10.14219/jada.archive.2001.0382
  6. Zeng Y, Opeskin K, Baldwin ME et al : Expression of vascular endothelial cell growth factor reseptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 10 : 5137, 2004 https://doi.org/10.1158/1078-0432.CCR-03-0434
  7. Shibuya M, Claesson-Welsh L : Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312 : 549, 2006 https://doi.org/10.1016/j.yexcr.2005.11.012
  8. He Y, Rajantie I, Pajusola K et al : Vascular endothelial cell growth factor reseptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65 : 4739, 2005 https://doi.org/10.1158/0008-5472.CAN-04-4576
  9. Scavelli,C.,Weber E., Agliano.M. et al : Lymphatics at the crossroads of angiogenesis and lyimphangiogenesis. J Anat 204 : 433, 2004 https://doi.org/10.1111/j.0021-8782.2004.00293.x
  10. McGeown JG, McHale.NG, Thornbury KD : The role of external compression and movement in lymph propulsion in the sheep hind limb. J Physiol 387 : 83, 1987 https://doi.org/10.1113/jphysiol.1987.sp016564
  11. Yokoyama Y, Chanrnock-Jones DS, Licence D et al : Vascular endothelial growth fator-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88 : 237, 2003 https://doi.org/10.1038/sj.bjc.6600701
  12. Renvi-Vamos F, Tovari J, Fillinger J et al : Lymphangiogenesis correlates with lymph node metastasis. prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 11 : 7344, 2005 https://doi.org/10.1158/1078-0432.CCR-05-1077
  13. Zeng Y, Opeskin K, Horvath LG et al : Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65 : 222, 2005 https://doi.org/10.1002/pros.20288
  14. Schoppmann SF, Bayer G, Aumayr K et al : Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240 : 306, 2004 https://doi.org/10.1097/01.sla.0000133355.48672.22
  15. Kitadai Y, Kodama M, Cho S et al : Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115 : 388, 2005 https://doi.org/10.1002/ijc.20859
  16. Shushanov S, Bronstein M, Adelaide J et al : VEGF-C and VEGFR3 expression in human thyroid pathologies. Int J Cancer 86 : 47, 2000 https://doi.org/10.1002/(SICI)1097-0215(20000401)86:1<47::AID-IJC7>3.0.CO;2-R
  17. Bock JM, Sinclair LL, Bedford NS et al : Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 134(4) : 355, 2008 https://doi.org/10.1001/archotol.134.4.355
  18. Ku SJ, Chang YI, Chae CH et al : Static tensional forces increase osteogenic gene expression in three-dimensional periodontal ligament cell culture. BMB reports 42(7) : 427, 2009
  19. Sleeman JP : The lymph node as a bridgehead in the metastatic dissemination of tumours. Recent Results Cancer Res 157 : 55, 2000
  20. Stacker SA, Williams RA Achen MG (2004) Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 112 : 539, 2004 https://doi.org/10.1111/j.1600-0463.2004.apm11207-0812.x
  21. Achen MG, Jeltsch M, Kukk E et al : Vascular endothelial growth fator-D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flk4). Proc Natl Acad Sci USA 95 : 548, 1998 https://doi.org/10.1073/pnas.95.2.548
  22. Wigle JT Oliver G : Proxl function is required for the development of the murine lymphatic system. Cell 98 : 769, 1999 https://doi.org/10.1016/S0092-8674(00)81511-1
  23. Cupedo T, Mebius RE : Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin Immunil 15 : 243, 2003 https://doi.org/10.1016/j.smim.2003.08.002
  24. Neuchrist C, Erovic BM, Handisurya A et al : Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25(6) : 464, 2003 https://doi.org/10.1002/hed.10235
  25. Saharinen P, Tammela T, Karkkainen MJ et al : Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation, Trends Immunol 25 : 387, 2004 https://doi.org/10.1016/j.it.2004.05.003
  26. Oliver G, Detmar M : The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16 : 773, 2002 https://doi.org/10.1101/gad.975002
  27. Wey JS, Stoeltzing O, Ellis LM : Vascular endothelial growth factor receptors: expression and function in solid tumors. Clin Adv Hematol Onco 2(1) : 37, 2004
  28. Witte D, Thomas A, Ali N et al : Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 22(3) : 1463, 2002
  29. Neuchrist C, Erovic BM, Handisurya A et al : Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinoma of the head and neck. Laryngoscope 111 : 1834, 2001 https://doi.org/10.1097/00005537-200110000-00031
  30. Beierle EA, Dai W, Langham MR et al : VEGF receptors are differentially expressed by neuroblastoma cells in culture. J Pediatr Surg 38(3) : 514, 2003 https://doi.org/10.1053/jpsu.2003.50091